|Titre :||Comorbidity of substance misuse and mental illness in community mental health and substance misuse services (2003)|
|Auteurs :||T. WEAVER ; P. MADDEN ; V. CHARLES ; G. STIMSON ; A. RENTON ; P. TYRER ; T. BARNES ; C. BENCH ; MIDDLETON H. ; N. WRIGHT ; S. PATERSON ; W. SHANAHAN ; N. SEIVEWRIGHT ; C. FORD ; COMORBIDITY OF SUBSTANCE MISUSE AND MENTAL ILLNESS COLLABORATIVE STUDY TEAM|
|Type de document :||Article : Périodique|
|Dans :||British Journal of Psychiatry (Vol.183, n°4, October 2003)|
|Article en page(s) :||304-313|
|Discipline :||PSY (Psychopathologie / Psychopathology)|
Thésaurus TOXIBASETROUBLE BIPOLAIRE ; PRODUIT ILLICITE ; COMORBIDITE ; ENQUETE ; MEDICAMENTS ; ALCOOL ; ANXIETE ; DEPRESSION ; PSYCHOSE ; ETUDE TRANSVERSALE ; STRUCTURE DE PROXIMITE
BACKGROUND: Improved management of mental illness and substance misuse comorbidity is a National Health Service priority, but little is known about its prevalence and current management.
AIMS: To measure the prevalence of comorbidity among patients of community mental health teams (CMHTs) and substance misuse services, and to assess the potential for joint management.
METHOD: Cross-sectional prevalence survey in four urban UK centres.
RESULTS: Of CMHT patients, 44% (95% CI 38.1-49.9) reported past-year problem drug use and/or harmful alcohol use; 75% (95% CI 68.2-80.2) of drug service and 85% of alcohol service patients (95% CI 74.2-93.1) had a past-year psychiatric disorder. Most comorbidity patients appear ineligible for cross-referral between services. Large proportions are not identified by services and receive no specialist intervention.
CONCLUSIONS: Comorbidity is highly prevalent in CMHT, drug and alcohol treatment populations, but may be difficult to manage by cross-referral psychiatric and substance misuse services as currently configured and resourced.
|Domaine :||Plusieurs produits / Several products|
|Refs biblio. :||34|
|Affiliation :||Dpt of Social Science and Medicine, Imperial College London, Charing Cross Campus, The Reynolds Building, St Dunstan's Rd, London, UK|
|Numéro Toxibase :||1300804|
|Centre Emetteur :||13 OFDT|